This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.
PRESS RELEASE from provider: Business Wire
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.

United States Contraceptive (Pill, IUD, Diaphragm, Subdermal Implant, Condom, Vaginal Ring, Sponge, Injectable, Patch) Market 2014-2018 & 2019-2025 - ResearchAndMarkets.com

March 13, 2019

DUBLIN--(BUSINESS WIRE)--Mar 13, 2019--The “U.S. Contraceptive Market Size, Share & Trends Analysis Report By Product (Pill, IUD, Diaphragm, Subdermal Implant, Condom, Vaginal Ring, Sponge, Injectable, Patch), And Segment Forecasts, 2018 - 2025” report has been added to ResearchAndMarkets.com’s offering.

The U.S. contraceptive market size is expected to reach at USD 11.6 billion by 2025 expanding at a CAGR of 5.3% over the forecast period.

Increasing awareness about long-acting reversible contraceptive is expected to augment the product demand, thereby driving the market over the next few years. Availability of various contraceptive options for both men and women and growing awareness about the use of contraceptive among teens in the region are also likely to fuel the U.S. contraceptive market.

Furthermore, recent mergers & acquisitions along with commercialization of newer drugs and devices are likely to propel the market growth over the forecast period. For instance, in July 2015, a new diaphragm, Caya, launched in U.S. after 50 years of gap. The device is 94% effective when used perfectly. Among different contraceptive product types, oral contraceptive pills accounted for the largest share of the regional market in 2017 mainly due to its effectiveness, easy availability, and low costs.

Further key findings from the study suggest:

  • Condom segment accounted for the second-largest share of the market. This can be attributed to its ability to provide protection against Sexually Transmitted Diseases (STDs)
  • Intrauterine Device (IUD) segment accounted for the significant share in 2017 and is expected to register a CAGR of 6.7% during the forecast period
  • Subdermal implant segment is expected to observe the fastest growth during the forecast period due to its 100% effectivity, easy insertion and removal mechanism, and ability to prevent pregnancy for 3 to 5 years
  • Some of the key companies in the U.S. contraceptive market are Mayer Laboratories, Inc.; Teva Pharmaceutical Industries Ltd.; Bayer AG, Reckitt Benckiser Plc; Pfizer, Inc.; Cooper Surgical, Inc.; Church & Dwight Co., Inc.; and Merck & Co.

Key Topics Covered:

Chapter 1 Executive Summary

1.1 Market Snapshot

Chapter 2 Research Methodology

2.1 Information Procurement

2.2 Data Analysis

Chapter 3 Market Variables, Trends & Scope

3.1 Market Segmentation and Scope

3.1.1 Market driver analysis

3.1.2 Market restraint analysis

3.2 Penetration & Growth Prospects Mapping

3.3 U.S. Contraceptive Market - PESTLE Analysis

3.4 Industry Analysis - Porter’s

3.5 U.S. Contraceptive Market Competitive Landscape: Market Position Analysis (Based on Product Portfolio, Country Presence, and Recent Updates)

Chapter 4 U.S. Contraceptive Market : Product Estimates & Trend Analysis

4.1 U.S. Contraceptive Market: Product Analysis

4.2 Pill

4.3 Condom

4.3.1. Market estimates and forecast, 2014 - 2025 (USD Million)

4.3.2. Male Condom

4.3.3. Female Condom

4.4 Diaphragm

4.5 Sponge

4.6 Vaginal Ring

4.7 Subdermal Implant

4.8 IUD

4.8.1 Market estimates and forecast, 2014 - 2025 (USD Million)

4.8.2. Hormonal IUD

4.8.3. Nonhormonal IUD

4.9 Patch

4.10 Injectable

Chapter 5 Competitive Landscape

5.1 Strategy framework

5.2 Company Profiles

5.2.1 Church & Dwight Co., Inc. Company overview Financial performance Product benchmarking Strategic initiatives

5.2.2 Reckitt

5.2.3 Merck & Co. Inc.

5.2.4 Pfizer, Inc.

5.2.5 TEVA Pharmaceutical

5.2.6 Cooper Companies, Inc.

5.2.7 Mayer Laboratories, Inc.

5.2.8 Agile Therapeutics

For more information about this report visit https://www.researchandmarkets.com/research/kd3shk/united_states?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190313005553/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Women’s Health



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 03/13/2019 11:46 AM/DISC: 03/13/2019 11:46 AM